Newsletter | November 17, 2022

11.17.22 -- Inside Autonomous Supply Chain Planning

Featured Editorial
Industry Insights
Perspectives Of Value-Driven, Integrated Solutions In Gene Therapy

By unlocking the value of an integrated solutions provider, you can leverage a comprehensive suite of advanced technologies and expertise that will facilitate your path to market and benefit you for the lifetime of your product.

What Big CROs Don’t Want You To Know About Staffing Scalability For Phase 3 Studies

Don’t settle for recycled employees poached from other studies when therapeutically-aligned, passionate, and accountable personnel — eager to work on your specific study — are available.

Improve Sterility Assurance And Data Integrity In A 503B Compounding Pharmacy

Learn about implementing automated technologies like robotics to overcome growing issues with sterility assurance and data integrity.

Evolving Trends And Recommendations For Breakthroughs In The ATMP Space

Identify and examine the key trends in the advanced therapy medicinal product (ATMP) industry and explore their impact on companies across a range of concerns, including speed to market, efficiency, safety, and innovation.

Superior Biopharmaceutical Manufacturing Facilities Prioritize Cleaning & Disinfection During Design

Thorough consideration of cleaning/disinfection during facility design eases maintenance across the facility life cycle, optimizes workspace utility, and contributes to efficient facility operation.

Qualified Reference Standards: Setting The Standard For Product Quality

Qualified reference standards play a critical role in providing validated benchmarks to satisfy regulatory requirements pertaining to purity.

DMSO-Free Cryopreservation Formulation As An Alternative Cryopreservation Method For Cell-Based Therapies

Discover our DMSO-free chemically defined cryopreservation medium that has shown statistically significant improvements in post-thaw viable cell recovery and cell functionality when compared to DMSO-containing solutions.

Stability Characterization Of Vaccines, Gene Vectors, And Therapeutic Antibodies With Light Scattering

In this webinar, learn how light scattering techniques have become powerful tools for characterizing various attributes, including molar mass, size, aggregation, physical titer, thermal, and colloidal stability.

Gene Therapies: Transformative Medicines

Gene therapies are transformative medicines that hold promise for treating diverse, genetically-driven diseases. Explore the essential components of a gene therapy.

AAV Vector Manufacturing

Due to its therapeutic impact on a wide range of diseases and disorders, adeno-associated virus (AAV) gene therapy is one of the most promising advances in modern medicine.

Enabling Bioprocess Control With Successful Automation Strategies

In a recent live event with Bioprocess Online, industry experts at various stages of their automation journey discussed their approach to enhancing quality control and data integrity through automated technologies.

Media Adaptation For Suspension Cells

We review a procedure to adapt suspension CHO and 293 cultures, which also serves as a general protocol that has been successful with multiple other cell types and media.

Uniformity Of Gene Expression Measurements On The QuantStudio 7 Pro Real-Time PCR System

We demonstrate a system that combines all of the qPCR features scientists want in a single high-performance instrument so that you can optimize your research productivity.

From Cell Culture To Target Protein: Exploring The Benefits Of The 24-Well Filter Plate Workflow

Over the last five years, the use of 24-well cell culture plates in laboratory applications has substantially increased. This market segment has expanded at an estimated 14% compound annual growth rate (CAGR) — a pace that is expected to continue in coming years. This paper explores the evaluation of the potential applications for its new AcroPrep 24-well filter plate line, plus the time savings it can achieve in protein purification workflows.

Impact Of Modular & Vendor-Independent Fluid Management Solutions

Read how modular and vendor-agnostic end-to-end process solutions helped save CAPEX, while increasing process speed at different scales help reduce OPEX for a CDMO.

Manufacturing Automation Solutions For Allogeneic Cell Therapy Production

Breakthrough manufacturing automation for cell expansion, formulation, and working cell bank dispensing paves the way for the treatment of debilitating illness.

Successfully Delivering Critical Stem Cell Samples Across The Globe

To deliver multi-leg shipments of crucial stem cell samples on-time and within specifications, samples had to be collected from Japanese apheresis treatment centers and transported to a U.S. manufacturing plant within 24 hours.

What Every Clinical Team Should Consider Before The Next Protocol

Even though everyone applauds the renewed focus on patients as a positive development, some say it is time for biopharma companies to turn their attention to another audience: clinical trial participants.

Why Aren't We Using Reformulation More For New Injectable Drug Products?

With the significant financial costs and clinical risks involved in bringing a new injectable drug product to market, why isn’t reformulation or repurposing being used more often to meet these challenges? This interview with Dr. Tom Tice, one of the world’s leading experts on extended release injectables and implants, reviews current and emerging areas of reformulation focus and some best practices to get your strategy right.

Overcoming Commercialization Challenges For Cell & Gene Therapies

This panel discussion highlights technical and regulatory hurdles associated with development and manufacturing steps and strategies and solutions to facilitate development through commercialization.

New Podcast Episode
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.